{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:45:50Z","timestamp":1792082750245,"version":"4.4.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089012","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T22:21:34Z","timestamp":1392330094000},"page":"e89012","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Endothelial Activation by Platelets from Sickle Cell Anemia Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Renata","family":"Proen\u00e7a-Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via","family":"Brugnerotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Tonin","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venina Marcela","family":"Dominical","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana Morelli","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene de F\u00e1tima Reis","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Ercolin","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Olalla-Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Conran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"MJ Stuart","year":"2004","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03630260802625709","article-title":"Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion","volume":"33","author":"N Conran","year":"2009","journal-title":"Hemoglobin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archneur.64.11.1567","article-title":"Big strokes in small persons","volume":"64","author":"RJ Adams","year":"2007","journal-title":"Arch Neurol"},{"key":"ref4","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","author":"E Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"key":"ref5","article-title":"Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial doppler velocity, and hydroxyurea treatment","author":"DC Noubouossie","year":"2013","journal-title":"Eur J Haematol"},{"key":"ref6","first-page":"169","article-title":"Enhanced thrombin generation in children with sickle cell disease","volume":"71","author":"M Peters","year":"1994","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15513810109168816","article-title":"Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology","volume":"20","author":"MJ Stuart","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"ref8","first-page":"105","article-title":"Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis","volume":"19","author":"RB Francis Jr","year":"1989","journal-title":"Haemostasis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2141.2012.09065.x","article-title":"Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis","volume":"157","author":"BN Setty","year":"2012","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1538-7836.2012.04861.x","article-title":"Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia","volume":"10","author":"MP Colella","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"A Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism","volume":"33","author":"MW Kenny","year":"1980","journal-title":"J Clin Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.1998.00627.x","article-title":"Platelet activation in patients with sickle cell disease","volume":"100","author":"T Wun","year":"1998","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2010.08087.x","article-title":"Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity","volume":"149","author":"R Proenca-Ferreira","year":"2010","journal-title":"Br J Haematol"},{"key":"ref15","first-page":"137","article-title":"Platelet function in sickle cell disease during steady state","volume":"32","author":"P Triadou","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3476(80)80804-3","article-title":"Abnormalities of platelet aggregation in sickle cell disease","volume":"96","author":"P Mehta","year":"1980","journal-title":"J Pediatr"},{"key":"ref17","first-page":"172","article-title":"Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry","volume":"18","author":"A Tomer","year":"2004","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"SP Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2012.09218.x","article-title":"Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease","volume":"158","author":"VT Garrido","year":"2012","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R","article-title":"Disturbance of plasma and platelet thrombospondin levels in sickle cell disease","volume":"51","author":"PV Browne","year":"1996","journal-title":"Am J Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajh.22274","article-title":"Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates","volume":"87","author":"EM Novelli","year":"2012","journal-title":"Am J Hematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"A Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"T Wun","year":"1997","journal-title":"J Lab Clin Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","article-title":"Thrombophilia in sickle cell disease: the red cell connection","volume":"98","author":"BN Setty","year":"2001","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.V96.3.1119","article-title":"Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation","volume":"96","author":"BN Setty","year":"2000","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","article-title":"P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease","volume":"30","author":"R Polanowska-Grabowska","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2257.2002.t01-1-00433.x","article-title":"Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease","volume":"24","author":"T Wun","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"J Villagra","year":"2007","journal-title":"Blood"},{"key":"ref29","article-title":"Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease","author":"TM Sakamoto","year":"2013","journal-title":"Clin Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1074-7613(95)90112-4","article-title":"Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis","volume":"3","author":"TS Finco","year":"1995","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"PJ Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1038\/sj.onc.1203218","article-title":"Diverse agents act at multiple levels to inhibit the Rel\/NF-kappaB signal transduction pathway","volume":"18","author":"JC Epinat","year":"1999","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"A Hidalgo","year":"2009","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","article-title":"Activated platelets can deliver mRNA regulatory Ago2.microRNA complexes to endothelial cells via microparticles","volume":"122","author":"B Laffont","year":"2013","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"JD Belcher","year":"2000","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2146\/ajhp090229","article-title":"Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature","volume":"67","author":"L Charneski","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000207105","article-title":"Therapeutic effect of aspirin in sickle cell anaemia","volume":"66","author":"NO Osamo","year":"1981","journal-title":"Acta Haematol"},{"key":"ref38","first-page":"574","article-title":"Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises","volume":"66","author":"H Chaplin Jr","year":"1989","journal-title":"East Afr Med J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1650055","article-title":"Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises","volume":"43","author":"H Chaplin Jr","year":"1980","journal-title":"Thromb Haemost"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-6-17","article-title":"A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease","volume":"6","author":"T Wun","year":"2013","journal-title":"J Hematol Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/bcp.12042","article-title":"A Phase 1 Study of Prasugrel in Patients with Sickle Cell Disease: Pharmacokinetics and Effects on ex Vivo Platelet Reactivity","volume":"75","author":"JA Jakubowski","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2007.06787.x","article-title":"Phase I study of eptifibatide in patients with sickle cell anaemia","volume":"139","author":"SP Lee","year":"2007","journal-title":"Br J Haematol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2013.08.002","article-title":"A Pilot Study of Eptifibatide for Treatment of Acute Pain Episodes in Sickle Cell Disease","volume":"132","author":"PC Desai","year":"2013","journal-title":"Thromb Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:36:43Z","timestamp":1597487803000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089012"}},"subtitle":[],"editor":[{"given":"Wilbur","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089012","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}